Mark H. Michalski, MD is the Worldwide Head Healthcare & Life Sciences AI/ML BD at Amazon/AWS, where he works with strategic healthcare and life science partners to advance AI/ML in the cloud. Previously, Dr. Michalski was faculty at Harvard Medical School, where he launched the Center for Clinical Data Science (CCDS)—a research center of excellence embedded within the world-class Mass Gen Brigham provider system. The CCDS launched over a dozen AI/ML solutions, and secured strategic partnerships with GE, Nvidia, Nuance, and Fuji to commercialize its technology.
Dr. Michalski has held leadership and operational roles at early-stage companies in the medical software and device domain, including Butterfly Network (a point-of-care ultrasound company) as president and CMO and Hyperfine Research (a portable MRI system company) as CMO. Both organizations successfully went public in 2021. Dr. Michalski has also worked intersection of technology and the drug development, working with global biopharma clients as the AI/ML practice lead at Headland Strategy Group, and held additional life science-focused roles at Google and Genentech.
Dr. Michalski completed his radiology residency training as a Holman Fellow at Yale-New Haven Hospital. He graduated with a degree in Cybernetics from the University of California at Los Angeles with multiple honors and received his medical degree from Stanford University.